© Borgis - Postępy Nauk Medycznych 4/2013, s. 290-295
*Justyna Domienik-Karłowicz1, Olga Dzikowska-Diduch1, Wojciech Lisik2, Andrzej Chmura2, Piotr Pruszczyk1
Ocena grubości kompleksu błona środkowa – błona wewnętrzna tętnicy szyjnej wspólnej u pacjentów z otyłością olbrzymią poddawanych operacjom bariatrycznym
Common carotid intima-media thickness assessment in morbidly obese patients undergoing bariatric surgery
1Department of Internal Medicine and Cardiology, Medical University of Warsaw
Head of Department: prof. Piotr Pruszczyk, MD, PhD
2Department of General and Transplant Surgery, Medical University of Warsaw
Head of Department: prof. Andrzej Chmura, MD, PhD
Wstęp. Otyłość definiuje się jako patologiczne nagromadzenie tkanki tłuszczowej w organizmie prowadzące do rozwoju chorób, w tym chorób układu sercowo-naczyniowego.
Cel. Celem badania była ocena grubości kompleksu błona środkowa – błona wewnętrzna tętnicy szyjnej wspólnej (IMT) w grupie pacjentów z otyłością olbrzymią, jak również ocena wpływu chirurgii bariatrycznej na badany parametr.
Materiał i metody. U wszystkich 40 pacjentów wykonano pomiary antropometryczne, oznaczono podstawowe parametry laboratoryjne oraz dokonano oceny IMT (Philips iE 33 system; Andeouver, Massachusetts USA). Protokół badania został zaakceptowany przez Komisję Bioetyczną przy Warszawskim Uniwersytecie Medycznym w Warszawie.
Results. Masa ciała pacjentów z otyłością olbrzymią zmieniła się w ciągu 6-miesięcznej obserwacji pooperacyjnej (132,03 ± 18,42 vs. 97,46 ± 15,35 kg; p < 0,0001 ze zmniejszeniem tłuszczowej masy ciała 49,15 ± 3,83% (OB1) vs. 38,20 ± 5,66% (OB2), (p < 0,0001). Grubość kompleksu błona wewnętrzna – błona środkowa różniła się pomiędzy grupami OB1 oraz OB2 (0,59 ± 0,11 vs. 0,52 ± 0,011 mm; p < 0,0001), ale nie przekraczała normy (IMT < 0,9 mm). Wartości IMT w GK były niższe niż w OB1 i wynosiły 0,42 ± 0,026 mm (p = 0,0001). W OB1 IMT korelowała z masą ciała (r = 0,472; p = 0,002), beztłuszczową masą ciała (r = 0,427, p = 0,0059), tłuszczową masą ciała (r = 0,368, p = 0,019), BMI (r = 0,423; p = 0,006), HbA1C (r = 0,296; p = 0,063).
Wnioski. Nieinwazyjna ocena IMT w grupie pacjentów z otyłością olbrzymią, w porównaniu do grupy osób zdrowych wskazuje na ich niekorzystne zmiany w grupie pacjentek z otyłością olbrzymią, w porównaniu do grupy osób zdrowych. Redukcja masy ciała w wyniku operacji bariatrycznej u pacjentów z otyłością olbrzymią prowadzi do obniżenia IMT oraz do korzystnych zmian metabolicznych.
Introduction. Obesity is a pathological accumulation of adipose tissue in the organism, and leads to the development of diseases, including cardiovascular diseases.
Aim. The aim of the study was to assess common carotid artery intima-media thickness in morbidly obese patients as well as to study the influence of bariatric surgery on studied parameter.
Material and methods. In all 40 patients we performed: anthropometric, basic laboratory measurement and common carotid artery intima-media thickness, (IMT), (Philips iE 33 system: Andeouver, Massachusetts USA). The protocol was approved by Warsaw Medical University’s Bioethics Committee.
Results. Body mass of patients diagnosed with severe obesity changed during the 6-month follow-up post-surgery period (132.03 ± 18.42 vs. 97.46 ± 15.35 kg; p < 0.0001). Fat mass decreased similarly: 49.15 ± 3.83% (OB1) vs. 38.20 ± 5.66% (OB2); (p < 0.0001). Intima-media thickness varied statistically between both groups (OB1, OB2) (0.59 ± 0.11 vs. 0.52 ± 0.011 mm; p < 0.0001), and were within the reference value range (IMT < 0.9 mm). In the control group IMT values were lower than in OB1 (0.59 ± 0.11 vs. 0.42 ± 0.026 mm; p = 0.0001). In OB1 IMT correlated with body mass (r = 0.472; p = 0.002), free fatty mass (r = 0.427, p = 0.0059), fatty mass (r = 0.368, p = 0.019), BMI (r = 0.423; p = 0.006), HbA1C (r = 0.296; p = 0.063).
Conclusions. Noninvasive assessment of common carotid artery IMT showed unfavorable change in the group of morbidly obese patients in comparison to healthy persons. Weight reduction as a result of bariatric surgery leads to the decrease in IMT as well as beneficial metabolic changes.
Obesity as a cardiovascular risk factor
Obesity, according to World Health Organisation definition, is a pathological accumulation of adipose tissue in the organism, and leads to the development of diseases, including cardiovascular diseases (1). Available data on epidemiology of obesity report that obesity occurs in 21.2% men and 22.4% women, in which 0.6% men and 2.2% of women are morbidly obese (2). Moreover, NATPOL study (2011) suggests that number of obese patients in 2035 increases from 22% to 33%, that is from 6.5 mln to more than 9 mln patients. Morbidly obese patients constitutes a group of patients with significantly increased cardiovascular risk. These patients characteristically more frequently suffer from different co-morbidities such as glucose disturbances, hypertension, sleep apnea, venous thromboembolism. Numerous epidemiological studies confirm significant influence of obesity on morbidity and mortality caused by cardiovascular incidents as well as on increase in number of complications caused by cardiac incidents (3). The meta-analysis of 15 studies, conducted in European Heart Journal, including 258 114 patients, showed that increase in waist circumference by 1 cm caused 2% increase in the incidence of cardiovascular diseases. Moreover increase in WHR by 0,01 is related to increase in the cardiovascular risk by 5% (4).
Bariatric surgery is a recognized method of treatment in patients with morbid obesity (5). The indications for surgery in the group of patients are BMI ≥ 40 kg/m2 or BMI 35-40 kg/m2 with co-morbidities, whose degree can potentially decrease as a result of weight reduction (metabolic diseases, cardiopulmonary diseases) (5).
Non-invasive assessment of infima-media thickness
According to actual recommendations of European Society of Hypertension and European Society of Cardiology increase in intima-media thickness (IMT) is a subclinical surrogate of morphological abnormalities of arterial walls (6-8). Arterial wall consists of three layers: the intima, media and adventitia (9). Primarily, Pignoli et al. in Circulation in 1986 revealed that assessment of common carotid artery intima-media thickness in ultrasonography correlates with its histopathological assessment (10). On a longitudinal, two-dimensional ultrasound image of the common carotid artery, the anterior and posterior walls of the carotid artery are displayed as two bright white lines. The distance between the leading edge of the first bright line of the far wall (lumen-intima interface) and the leading-edge of the second bright line (media-adventitia interface) indicates the intima-media thickness (10). According to quotabled over european guidelines IMT value more than 0.9 mm indicates abnormality (11). Based on meta-analysis performed by Lorenz et al. in the group of 37 000 patients, increase in IMT by 0,1 mm is related to 10-15% increase in risk of myocardial infarction and 13-18% increase in risk of stroke (11).
Multiple studies enabled us to assess the risk of leading or non-leading to death cardiovascular incidents, based on IMT measurements (12, 13). According to American College of Cardiology Foundation/American Heart Association (2010) recommendations regarding to cardiovascular risk assessment in asymptomatic patients, IMT measurement referred to IIa in the group of patients with intermediate risk (14). Thus, common carotid artery IMT is recognized as a marker of cardiovascular incidents in asymptomatic patients with type 2 diabetes and supporting parameter of cardiovascular risk assessment using Framingham scale (15, 16). Mannheim’s consensus authors recommended IMT assessment in all patients with suspected vascular disease (17).
Available data on the influence of antihypertensive treatment on IMT values are equivocal (18). Tropeano et al. in their meta-analysis confirmed significant decrease in IMT in the group of patients undergoing antihypertensive therapy in comparison to the control group undergoing therapy based on placebo: -0.10 (-0.16; -0.04) (18).
The aim of the study was to assess common carotid artery intima-media thickness in morbidly obese patients. Pararelly, we wanted to compare received results to controls’ group results as well as to results in studied group after 6 months bariatric surgery follow-up.
MATERIAL AND METHODS
For the prospective analysis we included 40 patients with severe obesity, admitted to the Department of Internal Medicine and Cardiology for qualification for bariatric surgery procedures (OB1) and reassessed six months after the surgery (OB2). There were 15 healthy women with normal body mass in the control group. They were matched for age and sex with OB1/OB2. In all cases undergoing our study we performed: physical examination, anthropometric analysis (height, body mass, fat mass, free fatty mass), basic laboratory analysis (morphology, lipidogram, GOT, GPT, creatinine, hsCRP, HbA1C, fasting glucose, two-hour glucose levels on the OGTT), common carotid artery intima-media thickness (IMT). The patients suffered from hypertension were analyzed during standard treatment according to Eurpean Society of Cardiology guidelines. Angiotensin converting enzyme inhibitors, diuretics and in some cases calcium-antagonists were used. Then, all patients undergone bariatric surgery. All assessments were repeated six months after surgery. The same protocol was performed in the control group.
Common carotid artery intima-media thickness was performed in the morning, after 12 hours at rest, on the base of 3 measurements in both common carotid arteries. The measurements were performed according to accepted protocol using ultrasound Philips iE 33 system (Andeouver, Massachusetts USA) with linear probe (5-7 MHz). All measurements were performed and assessed by one doctor.
For the statistical analysis of the material to describe the quantitative variables, we used standard descriptive statistics. For quantitative variables was tested the hypothesis that the distribution of the features compatibility with a normal distribution (Shapiro-Wilk test, test type graphical QQ). In the case when the distribution of the characteristics was normal, we tested the hypothesis of the equality of the means for the two groups, using the T-test. When comparing the two groups for traits showing deviations from the normal distribution, we used Wilcoxon test for independent samples. By analyzing changes in quantitative parameters during treatment, we used t-test for the characteristics of normal distributions and the Wilcoxon test for the characteristics of the other distributions. Analyzing correlations for quantitative variables, we used Pearson’s coefficient for the characteristics of normal distributions and Spearman coefficient for the characteristics of the other distributions. The relationship between qualitative variables was tested in the system of contingency tables using the chi-square test or Fisher’s exact test when the expected values in table cells were not sufficiently large (ie. more than 5). By analyzing changes in quality parameters during treatment test, we used the test of symmetry related (McNemar’s test). When analyzing the impact of some factors on IMT, we used multivariate generalized linear models (GLM). The GLM models were selected optimal forms: combining function and the distribution of the error. The selection of the optimal model used stepwise variable selection strategy. As a criterion for the selection of model fit assumed statistical minimum AIC (Akaike’s Information Criterion). To describe the model fits the data statistics, we used Pearson Chi-Square and pseudo R-Square. The level of statistically significant value of p was < 0.05.
The protocol was approved by Warsaw Medical University’s Bioethics Committee on 31.03.2009 (KB/64/2009). The research project was co-financed with funds of Ministry of Science and Higher Education (N N402 490240).
General clinical characteristics of studied groups
The anthropometric results of patients undergoing bariatric surgery as well as control group were presented in table 1.
Table 1. Anthropometric results of patients undergoing bariatric surgery as well as control group.
| ||Patients before surgery (OB1)||Patients 6-months after surgery (OB2)||Control group (CG)|
|Body mass (kg)||132.03 ± 18.42||97.46 ± 15.35*||60.73 ± 5.12*|
|BMI (kg/m2)||47.73 ± 6.18||35.22 ± 5.20*||21.61 ± 1.41*|
|FAT (%)||49.15 ± 3.83||38.20 ± 5.66*||25.13 ± 4.88*|
|FFM (kg)||66.78 ± 7.84||59.90 ± 8.92*||45.37 ± 3.7*|
|BSA M (m2)||2.47 ± 0.20||2.12 ± 0.19*||1.68 ± 0.09*|
|EBW (kg)||72.34 ± 16.75||37.77 ± 13.97*|| |
*vs. OB1: p < 0.0001
Incidence of co-morbidities in morbidly obese patients
We recognized hypertension in 38 (95%) patients. At the time of surgery 30 (75%) patients received 2 or more antihypertensive drugs (including angiotensin-converting enzyme inhibitors and diuretics); and 8 (20%) patients only 1 antihypertensive drug (angiotensin-converting enzyme inhibitor). We recognized pre-diabetic state in 11 (27.5%) patients, among them 6 (15%) patients with impaired fasting glucose (IFG), and 7 (17.5%) with impaired glucose tolerance (IGT). We recognized both pre-diabetic states simultaneously in 2 (5%) patients. Patients with type 2 diabetes were excluded from the study. We recognized lipid abnormalities in 22 (55%) patients and moderate sleep apnea in 8 (20%) patients.
Basic biochemical parameters assessment in studied group
Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Płatny dostęp do wszystkich zasobów Czytelni Medycznej
1. World Health Organization: Obesity: Preventing and Managing the Global Epidemic (Who Technical Report Series). World Health Organisation.
2. Biela U, Pajak A, Kaczmarczyk-Chałas K et al.: Incidence of overweight and obesity in women and men between the ages of 20-74. Results of the WOBASZ program. Kardiol Pol 2005; 63 (6 Suppl 4): S632-635.
3. Lloyd-Jones D, Adams RJ, Brown TM et al.: Executive summary: heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation 2010; 121(7): 948-954.
4. de Koning L, Merchant AT, Pogue J, Anand SS: Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28(7): 850-856.
5. Fried M, Hainer V, Basdevant A et al.: Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg 2007; 17(2): 260-270.
6. Mancia G, De Backer G, Dominiczak A et al.: 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Rev Esp Cardiol 2007; 60(9): 968 e1-94.
7. Lekakis J, Abraham P, Balbarini A et al.: Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil 2011; 18(6): 775-789
8. Mancia G, De Backer G, Dominiczak A et al.: 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28(12): 1462-536.
9. Kumar V, Stanley L, Robbins RSC: Patologia. 2005.
10. Pignoli P, Tremoli E, Poli A et al.: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74(6): 1399-1406.
11. Lorenz MW, Markus HS, Bots ML et al.: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115(4): 459-467.
12. Bots ML, Hoes AW, Koudstaal PJ et al.: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96(5): 1432-1437.
13. Nambi V, Chambless L, He M et al.: Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J 2011; 33(2):183-190.
14. Greenland P, Alpert JS, Beller GA et al.: 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary. Circulation 2010; 122(25): 2748-2764.
15. Polak JF, Pencina MJ, Pencina KM et al.: Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011; 365(3): 213-221.
16. Yoshida M, Mita T, Yamamoto R et al.: The Combination of Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients With Type 2 Diabetes. Diabetes Care 2011; 35(1): 178-180.
17. Touboul PJ, Hennerici MG, Meairs S et al.: Mannheim Carotid Intima-Media Thickness Consensus (2004-2006). Cerebrovascular Diseases 2007; 23(1): 75-80.
18. Tropeano AI, Saleh N, Hawajri N et al.: Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2011; 25(3): 395-404.
19. Sarmento PL, Plavnik FL, Zanella MT et al.: Association of carotid intima-media thickness and cardiovascular risk factors in women pre- and post-bariatric surgery. Obes Surg 2009; 19(3): 339-344.
20. Polak JF, Pencina MJ, Herrington D, O’Leary DH: Associations of edge-detected and manual-traced common carotid intima-media thickness measurements with Framingham risk factors: the multi-ethnic study of atherosclerosis. Stroke 2011; 42(7): 1912-1916.
21. Crouse JR 3rd, Grobbee DE, O’Leary DH et al.: Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis-the rationale and methodology of the METEOR study. Cardiovasc Drugs Ther 2004; 18(3): 231-238.